From April 17th to 19th, 2024, the 21st CPHI Japan concluded successfully in Tokyo. As Japan’s leading pharmaceutical exhibition, the event attracted nearly 600 exhibitors from around the world and set a record for attendance, with nearly ten thousand professionals from the pharmaceutical industry gathering to witness this grand occasion.
Dorra Pharma, a leading integrated operator with core competitive advantage in global pharmaceutical market, showcased its latest product layouts and CDMO solutions during the event, earning high praise from customers and becoming a focal point for the event. Throughout the exhibition, Dorra Pharma engaged in in-depth discussions with industry experts, partners, and customers from across the globe, sharing the company’s recent achievements and future directions, garnering widespread recognition and appreciation.
The three-day CPHI Japan exhibition not only deepened the Dorra Pharma business team’s understanding of the industry’s current state but also promoted the company’s overseas market expansion and internationalization strategy. This event further strengthened Dorra Pharma’s international and professional image, providing valuable opportunities for establishing new business contacts and strengthening existing partnerships, thereby solidifying the company’s position in the global pharmaceutical market and laying a solid foundation for future development.
Looking ahead, Dorra Pharma will continue to strive to create more valuable products for health the life.
Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 苏ICP备12056923号-1